These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19726307)

  • 1. [Establishment of homogeneous time-resolved fluorescence immunoassay for high throughput screening of protein tyrosine kinase inhibitors].
    Li XG; Wang GF; Zhang JY; Wu SY; Xu W; Wu SG; Zhang JJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1612-4. PubMed ID: 19726307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A widely applicable, high-throughput TR-FRET assay for the measurement of kinase autophosphorylation: VEGFR-2 as a prototype.
    Moshinsky DJ; Ruslim L; Blake RA; Tang F
    J Biomol Screen; 2003 Aug; 8(4):447-52. PubMed ID: 14567797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinase inhibitory activity of dehydroabietylamine derivatives tested by homogeneous time-resolved fluorescence based high throughput screening model.
    Zhou TT; He L; Yan M; Zhang LY; He JG; Rao XP
    Chin J Nat Med; 2013 Sep; 11(5):506-13. PubMed ID: 24359775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTK 787/ZK 222584, a tyrosine kinase inhibitor of all known VEGF receptors, represses tumor growth with high efficacy.
    Hess-Stumpp H; Haberey M; Thierauch KH
    Chembiochem; 2005 Mar; 6(3):550-7. PubMed ID: 15742376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homogeneous single-label tyrosine kinase activity assay for high throughput screening.
    Tong-Ochoa N; Kopra K; Syrjänpää M; Legrand N; Härmä H
    Anal Chim Acta; 2015 Oct; 897():96-101. PubMed ID: 26515010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, in silico, in vitro, and in vivo investigation of 5-[¹¹C]methoxy-substituted sunitinib, a tyrosine kinase inhibitor of VEGFR-2.
    Caballero J; Muñoz C; Alzate-Morales JH; Cunha S; Gano L; Bergmann R; Steinbach J; Kniess T
    Eur J Med Chem; 2012 Dec; 58():272-80. PubMed ID: 23131541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of high-throughput TR-FRET and AlphaScreen assays for identification of potent inhibitors of PDK1.
    Xu Z; Nagashima K; Sun D; Rush T; Northrup A; Andersen JN; Kariv I; Bobkova EV
    J Biomol Screen; 2009 Dec; 14(10):1257-62. PubMed ID: 19822882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence polarization competition immunoassay for tyrosine kinases.
    Seethala R
    Methods; 2000 Sep; 22(1):61-70. PubMed ID: 11020319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an AlphaScreen-based high-throughput screening assay for inhibitors of human vascular endothelial growth factor receptor-3.
    Wang K; Yang R; Xu J; Zhang Y; Zhu L; Lin J; Huang B
    J Immunoassay Immunochem; 2011; 32(3):219-32. PubMed ID: 21574093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer.
    Labots M; Gotink KJ; Dekker H; Azijli K; van der Mijn JC; Huijts CM; Piersma SR; Jiménez CR; Verheul HM
    Exp Mol Med; 2016 Dec; 48(12):e279. PubMed ID: 27980342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of benzamides and benzamidines as selective inhibitors of VEGFR tyrosine kinases.
    Nakamura H; Sasaki Y; Uno M; Yoshikawa T; Asano T; Ban HS; Fukazawa H; Shibuya M; Uehara Y
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5127-31. PubMed ID: 16893647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of protein tyrosine phosphorylation: preliminary assessment of activity by time-resolved fluorescence.
    Amir-Zaltsman Y; Mazor O; Gayer B; Scherz A; Salomon Y; Kohen F
    Luminescence; 2000; 15(6):377-80. PubMed ID: 11114114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical anti-angiogenesis and anti-tumor activity of SIM010603, an oral, multi-targets receptor tyrosine kinases inhibitor.
    Wang D; Tang F; Wang S; Jiang Z; Zhang L
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):173-83. PubMed ID: 21638122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YM-359445, an orally bioavailable vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor, has highly potent antitumor activity against established tumors.
    Amino N; Ideyama Y; Yamano M; Kuromitsu S; Tajinda K; Samizu K; Hisamichi H; Matsuhisa A; Shirasuna K; Kudoh M; Shibasaki M
    Clin Cancer Res; 2006 Mar; 12(5):1630-8. PubMed ID: 16533791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and comparison of nonradioactive in vitro kinase assays for NIMA-related kinase 2.
    Jin G; Aulabaugh A; Pocas J; Liu H; Kriz R; Sampath D
    Anal Biochem; 2006 Nov; 358(1):59-69. PubMed ID: 16962550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
    Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High throughput screening for human interferon-gamma production inhibitor using homogenous time-resolved fluorescence.
    Enomoto K; Aono Y; Mitsugi T; Takahashi K; Suzuki R; Préaudat M; Mathis G; Kominami G; Takemoto H
    J Biomol Screen; 2000 Aug; 5(4):263-8. PubMed ID: 10992047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening.
    Usui T; Ban HS; Kawada J; Hirokawa T; Nakamura H
    Bioorg Med Chem Lett; 2008 Jan; 18(1):285-8. PubMed ID: 17983745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment of an in vitro screening model for steroid 5 alpha-reductase inhibitors with the microplate reader].
    Wu JH; Sun ZY
    Zhonghua Nan Ke Xue; 2013 Jun; 19(6):483-6. PubMed ID: 23862223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and development of a peptide substrate-based phosphate transfer assay for the human vascular endothelial growth factor receptor-2 tyrosine kinase.
    Zhao G; Peery RB; Yingling JM
    Anal Biochem; 2007 Jan; 360(2):196-206. PubMed ID: 17141171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.